HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Table All Versions of this Article: 295/1/E17    most recent 90281.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Copeland, R. J. Articles by Hart, G. W. Search for Related Content PubMed PubMed Citation Articles by Copeland, R. J. Articles by Hart, G. W.

REVIEWS

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity

Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland

Submitted 10 March 2008 ; accepted in final form 25 April 2008

ABSTRACT

O-linked β-N-acetylglucosamine (O-GlcNAc) is a dynamic posttranslational modification that, analogous to phosphorylation, cycles on and off serine and/or threonine hydroxyl groups. Cycling of O-GlcNAc is regulated by the concerted actions of O-GlcNAc transferase and O-GlcNAcase. GlcNAcylation is a nutrient/stress-sensitive modification that regulates proteins involved in a wide array of biological processes, including transcription, signaling, and metabolism. GlcNAcylation is involved in the etiology of glucose toxicity and chronic hyperglycemia-induced insulin resistance, a major hallmark of type 2 diabetes. Several reports demonstrate a strong positive correlation between GlcNAcylation and the development of insulin resistance. However, recent studies suggest that inhibiting GlcNAcylation does not prevent hyperglycemia-induced insulin resistance, suggesting that other mechanisms must also be involved. To date, proteomic analyses have identified more than 600 GlcNAcylated proteins in diverse functional classes. However, O-GlcNAc sites have been mapped on only a small percentage (<15%) of these proteins, most of which were isolated from brain or spinal cord tissue and not from other metabolically relevant tissues. Mapping the sites of GlcNAcylation is not only necessary to elucidate the complex cross-talk between GlcNAcylation and phosphorylation but is also key to the design of site-specific mutational studies and necessary for the generation of site-specific antibodies, both of which will help further decipher O-GlcNAc's functional roles. Recent technical advances in O-GlcNAc site-mapping methods should now finally allow for a much-needed increase in site-specific analyses to address the functional significance of O-GlcNAc in insulin resistance and glucose toxicity as well as other major biological processes.

O-linked β-N-acetylglucosamine; diabetes; O-linked β-N-acetylglucosamine transferase; β-N-acetylglucosaminidase; hexosamine biosynthesis

This article has been cited by other articles:

				W. B. Dias, W. D. Cheung, Z. Wang, and G. W. Hart Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification J. Biol. Chem., August 7, 2009; 284(32): 21327 - 21337. [Abstract] [Full Text] [PDF]

				R. J. Chalkley, A. Thalhammer, R. Schoepfer, and A. L. Burlingame Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides PNAS, June 2, 2009; 106(22): 8894 - 8899. [Abstract] [Full Text] [PDF]

				A. Marette New insights in covalent modifications of proteins and lipids: phosphorylation and beyond Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E579 - E580. [Full Text] [PDF]

				S. Eguchi, N. Oshiro, T. Miyamoto, K.-i. Yoshino, S. Okamoto, T. Ono, U. Kikkawa, and K. Yonezawa AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity. Genes Cells, February 1, 2009; 14(2): 179 - 189. [Abstract] [Full Text] [PDF]

				Z. Wang, K. Park, F. Comer, L. C. Hsieh-Wilson, C. D. Saudek, and G. W. Hart Site-Specific GlcNAcylation of Human Erythrocyte Proteins: Potential Biomarker(s) for Diabetes Diabetes, February 1, 2009; 58(2): 309 - 317. [Abstract] [Full Text] [PDF]

				L. Zou, S. Yang, V. Champattanachai, S. Hu, I. H. Chaudry, R. B. Marchase, and J. C. Chatham Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H515 - H523. [Abstract] [Full Text] [PDF]

				B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28. [Abstract] [Full Text] [PDF]